Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 449884 (IONIS-GCGRRx) in Type 2 Diabetes on Metformin
NCT01885260Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Jul 2013
- Primary completion
- May 2014
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 2
01
Overview
A Phase 2 trial of ISIS 449884 in type 2 diabetes mellitus (T2DM), sponsored by Ionis Pharmaceuticals. Started Jul 2013; status: completed.
02
Drugs
ISIS 449884
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01885260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885260.